T-cell acute lymphoblastic leukemia

Leah SherwoodTransplantation & Cellular Therapy | July 29, 2022
The FDA has granted Fast Track Designation and Rare Pediatric Disease Designation for WU-CART-007.
Read More
Leah LawrenceT-Cell Lymphoma | April 4, 2022
WU-CART-007 is being tested as part of a phase 1/2 trial that will evaluate if use of the off-the-shelf therapy is safe and ...
Advertisement
Editorial Board

Advertisement